Moody Aldrich Partners’s Insmed INSM Stock Holding History

Moody Aldrich Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$324K	Sell	3,035 -9	-0.3%	-$1.09K	0.06%	146
2026 Q1	$498K	Sell	3,044 -1,992	-40%	-$306K	0.09%	134
2025 Q4	$876K	Sell	5,036 -515	-9%	-$94K	0.16%	120
2025 Q3	$799K	Buy	5,551 +132	+2%	+$16.2K	0.15%	115
2025 Q2	$545K	Sell	5,419 -83,601	-94%	-$6.39M	0.11%	123
2025 Q1	$6.79M	Buy	89,020 +53,542	+151%	+$4.1M	1.42%	17
2024 Q4	$2.45M	Buy	+35,478	New	+$2.56M	0.45%	86
2018 Q1	–	Sell	-31,046	Closed	-$968K	–	92
2017 Q4	$968K	Buy	31,046 +6,466	+26%	+$191K	0.78%	63
2017 Q3	$767K	Buy	24,580 +3,170	+15%	+$60.4K	0.79%	61
2017 Q2	$367K	Buy	21,410 +5,860	+38%	+$100K	0.46%	83
2017 Q1	$272K	Sell	15,550 -30,550	-66%	-$471K	0.47%	81
2016 Q4	$610K	Sell	46,100 -1,030	-2%	-$14.1K	0.39%	84
2016 Q3	$684K	Buy	+47,130	New	+$590K	0.48%	87

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Moody Aldrich Partners's INSM Position: Q2 2026 in Review

Moody Aldrich Partners reduced its Insmed (INSM) stake by 0.3% in Q2 2026, selling an estimated $1.09K and leaving 3,035 shares worth $324K. The position accounts for 0.06% of the portfolio, ranked #146.

Moody Aldrich Partners first reported a position in INSM in Q3 2016 and has held it in 13 quarters since. The position peaked at $6.79M in Q1 2025. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Moody Aldrich Partners held 3,035 shares of Insmed worth $324K as of Q2 2026.
Moody Aldrich Partners sold 9 Insmed shares in Q2 2026, an estimated $1.09K.
Insmed made up 0.06% of Moody Aldrich Partners's portfolio in Q2 2026, its #146 holding.
Moody Aldrich Partners first reported a position in Insmed in Q3 2016 and has held it in 13 quarters since.
Moody Aldrich Partners's Insmed position peaked at $6.79M in Q1 2025.
664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Moody Aldrich Partners's 13F filing for Q2 2026, filed 15 Jul 2026.